The Antimicrobial Advocate, Volume 2, Issue 10
Highlights from this month’s issue:
- The DOTS Trial – Dalbavancin for Treatment of Staphylococcus aureus Bacteremia
- PALTmed COVID-19 Vaccine Statement for Post-Acute and LTC
- IDSA COVID-19 Treatment Guidance



